ImmunoPrecise Antibodies
IPA2.0700.00% ( 0.000 )
Q4 FY2025 Earnings
Financial report interval: 2025.01.30 - 2025.04.30
Overview: ImmunoPrecise Antibodies(IPA) the Revenue is 5.045 M (+6.72%);the EBIT is -1.065 M (+62.51%);the EPS is -0.0341 (+92.95%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.01B6.72%
----
----
EBIT
-0.00B62.51%
----
----
EPS
-0.034192.95%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf